Press Release Tech Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries Libtayo (cemiplimab) is a leading PD-1 inhibitor that has shown efficacy in… CISION PRNewswireJanuary 8, 2024
Press Release Tech DEEPX CEO Lokwon Kim to Speak at CES 2024 Panel on the Future of AI Hardware and Chips Lokwon Kim represents global AI chip companies at a panel on innovations… CISION PRNewswireJanuary 8, 2024
Business Press Release Tech Recurrent Energy Completes Sale of 100 MW/200 MWh Battery Energy Storage Project in South Australia to Epic Energy GUELPH, ON, Jan. 8, 2024 /PRNewswire/ — Canadian Solar Inc. (the "Company"… CISION PRNewswireJanuary 8, 2024
Business Press Release Tech Origin Agritech Reports Fiscal Year End 2023 Results BEIJING, Jan. 8, 2024 /PRNewswire/ — Origin Agritech Ltd. (NASDAQ: SEED) (the… CISION PRNewswireJanuary 8, 2024
Business Press Release Tech Canadian Solar's e-STORAGE to Deliver 220 MWh DC of Battery Storage Solutions to Epic Energy's Mannum Project in South Australia GUELPH, ON, Jan. 8, 2024 /PRNewswire/ — Canadian Solar Inc. (the "Company" or… CISION PRNewswireJanuary 8, 2024
Business Press Release Tech SurplusGLOBAL's CEO, Bruce Kim, Has Been Elected as a Members of The National Academy of Engineering of Korea SEOUL, South Korea, Jan. 8, 2024 /PRNewswire/ — Bruce Kim, the CEO of… CISION PRNewswireJanuary 8, 2024
Press Release Tech The World's First Clinical Base Edting Therapy for Hemoglobinopathy CorrectSequence Therapeutics’ CS-101 Successfully Cures One Patient of Transfusion-Dependent β-Thalassemia SHANGHAI, Jan.… CISION PRNewswireJanuary 8, 2024
Business Press Release Biosion's Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC) – First clinical trial to evaluate the safety and efficacy of OBI-992… CISION PRNewswireJanuary 8, 2024
